Roza Avetisyan | Nuclear Physics | Women Researcher Award

Posted on by ScienceFather

Dr. Roza Avetisyan | Nuclear Physics | Women Researcher Award

A.I. Alikhanyan National Science Laboratory | Armenia

Dr. Roza Avetisyan is a distinguished researcher in the field of nuclear physics, currently serving as the Head of the Low Energy Nuclear Physics Group at the A.I. Alikhanyan National Science Laboratory in Yerevan, Armenia. With a Ph.D. in Physics, Avetisyan’s work spans over a decade of research and scientific contributions, particularly in nuclear reactions, medical isotopes, and accelerator-based physics.

👨‍🎓Profile

Google scholar

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Avetisyan’s academic journey began at Yerevan State University, where she earned her B.S. and M.S. degrees in Physics (2005-2011). Her early research focused on GEANT4 simulations and the spontaneous radiation of electron beams, setting the foundation for her future work in nuclear physics. She continued her academic trajectory by joining the A.I. Alikhanyan National Science Laboratory for her Ph.D., completing her dissertation in 2022 on “Study of the excitation functions and isomer ratios of proton and gamma-induced reactions,” under the mentorship of I.A. Kerobyan.

💼 Professional Endeavors

Roza’s career spans multiple roles at the A.I. Alikhanyan National Science Laboratory (AANL) in Armenia. Since 2012, she has evolved from an engineer physicist to the head of the Low Energy Nuclear Physics Group (since January 2023). She has also held key positions like Science Secretary and Researcher within the same group, contributing to various nuclear physics projects and fostering scientific collaboration. Her contributions extend to international partnerships, as she has also worked as a laboratory research visitor at the University of Notre Dame (2013).

🔬 Contributions and Research Focus

Dr. Roza Avetisyan’s research is primarily focused on low-energy nuclear physics, proton and gamma-induced reactions, and medical isotopes. Her key contributions include the investigation of excitation functions and isomer ratios in nuclear reactions, as well as the production of medical isotopes like 186gRe. Through her leadership at AANL, she has advanced studies on applied gadolinium radioisotopes, neutron flux formation, and isotope production using cyclotron beams. Her research plays a critical role in nuclear medicine and radiation safety.

Academic Cites 📑

Dr. Roza Avetisyan has authored multiple influential papers in nuclear physics, which have been cited in leading journals such as Nucl. Phys. A, The European Physical Journal A, and NIM B. Notable publications include works on the formation of 180mTa and the production of 186gRe. Her research on proton-induced reactions and excitation functions contributes to the understanding of nuclear processes and their applications in various sectors, including nuclear energy and medical isotope production.

👨‍🏫 Teaching Experience

While her primary focus is research, Dr. Avetisyan’s role as a research mentor and group leader at the AANL has involved training and guiding the next generation of physicists. Her participation in international workshops and summer schools reflects her commitment to educating young scientists in nuclear physics and accelerator technology.

Research Skills 🧠

Roza possesses advanced skills in nuclear reaction analysis, isotope production, and simulation tools like TALYS, EMPIRE, and GEANT4. She is proficient in using these tools to model and predict nuclear processes, which is critical for her research in low-energy nuclear physics and nuclear medicine. Furthermore, her experience with cyclotron facilities and bremsstrahlung beams enhances her research capabilities in both theoretical and applied physics.

Technical Skills ⚙️

Roza is well-versed in a range of technical skills essential for her research, including programming languages and simulation software. She is proficient in TALYS, EMPIRE, and SRIM/TRIM, which are crucial for simulating nuclear reactions and material interactions. Her proficiency extends to data analysis using OriginPro and SketchUp, enhancing her research in both theoretical calculations and experimental setups.

Legacy and Future Contributions 🌟

Roza Avetisyan’s legacy is firmly rooted in her contributions to low-energy nuclear physics and medical isotope research. As she continues to lead AANL’s Low Energy Nuclear Physics Group, her future work will likely focus on advancing nuclear spectroscopy and expanding the use of applied isotopes in medical and industrial applications. With her scientific leadership, Roza is poised to make lasting contributions to both scientific communities and nuclear medicine, potentially revolutionizing the way medical treatments are delivered using isotopes.

Top Noted Publications 

 

 

Jean-Marc Sabatier | Interactions and fields |Best Researcher Award

Posted on by ScienceFather

Dr. Jean-Marc Sabatier | Interactions and fields|Best Researcher Award

Director of research at CNRS, France

Jean-Marc Sabatier, born on January 20, 1961, is a distinguished French biochemist specializing in peptide design and toxinology. With an extensive career spanning over three decades, he has made significant contributions to the fields of drug synthesis, protein engineering, and diagnostic assay development. Currently affiliated with the CNRS UMR 7051, he has also held various leadership roles in prominent research institutions and biotech companies across France and Canada. Sabatier’s expertise is recognized globally, evident in his over 270 publications and 180 congress reports. His academic and professional journey is underscored by a commitment to innovation and collaboration in biochemistry.

Profile:

🎓Education:

Jean-Marc Sabatier obtained his Doctorate in Biochemistry and subsequently earned the Habilitation to Supervise Research (HDR). His educational foundation laid the groundwork for a prolific career in peptide and protein chemistry. His advanced training equipped him with the knowledge and skills to tackle complex biochemical challenges. Throughout his academic pursuits, he focused on optimizing peptide structures and exploring biochemical interactions, ultimately leading to groundbreaking research and innovative drug development. His academic credentials, combined with extensive practical experience, have made him a pivotal figure in biochemistry.

💼 Professional Endeavors

Over the years, Sabatier has held significant positions, including:

  • 2019-2024: Research Fellow at CNRS UMR 7051, Institute of Neurophysiopathology, France.
  • 2012-2019: Head of a Research Group at INSERM U1097.
  • 2009-2016: Chief Scientific Officer at Tournoux Biotech, France.
  • 2006-2011: Head of a combined University-Industry Research Laboratory focused on Therapeutic Peptides.

🔬 Contributions and Research Focus

Sabatie’s expertise encompasses a wide array of topics, including:

  • Drug design and synthesis, particularly of peptides and related compounds.
  • Optimization of peptide structures to enhance bioactivity, selectivity, and stability.
  • Development of peptide-based in vitro assays for diagnostics.

His research has led to over 270 publications and 180 congress reports in peptide and protein chemistry, with an impressive H-index of 51, indicating significant academic influence.

🌍 Impact and Influence

Sabatie’s work has had a substantial impact on various fields, including:

  • Toxinology and peptide-based drug development.
  • The design of diagnostic tests and therapeutic agents, including antiviral peptides.
  • His innovative contributions have garnered numerous awards, including the prestigious Citizen of the Year Award in 1993 for his anti-HIV peptide, SPC3.

📚 Academic Citations

His research is well-cited across various disciplines, with contributions to esteemed journals such as the Journal of Biological Chemistry and Pharmacological Research. He has also served as an associate editor for high-impact journals, enhancing the visibility and credibility of research in his field.

🔧 Technical Skills

Sabatie’s technical skills include:

  • Advanced drug design techniques and peptide synthesis.
  • Mass spectrometry and other analytical methods for evaluating peptides.
  • Expertise in developing peptide-based therapeutics and diagnostics.

🎓 Teaching Experience

With a background in academia, Sabatie has served in assistant professor positions at faculties of medicine and sciences, mentoring the next generation of scientists and fostering an environment of collaborative research.

🕊️ Legacy and Future Contributions

Jean-Marc Sabatier’s legacy is characterized by his commitment to advancing biochemistry and drug design. As he continues to contribute to research and academia, his work promises to influence future developments in peptide technology and therapeutic applications.

📖Publication Top Notes:

 Renin-Angiotensin System Dysregulation: ADAM17 Activation Consequences Related to SARS-CoV-2

               Authors: Julien Giacomoni; Jean-Marc Sabatier
               Publication Year: 2025

 SARS-CoV-2 or Vaccinal Spike Protein can Induce Mast Cell Activation Syndrome (MCAS)

              Authors: Ziad Fajloun; Ziad Abi Khattar; Jean-Marc Sabatier
              Publication Year: 2025

Vitamin D and Mitochondrial Activity Preservation in COVID-19

              Authors: Julien Giacomoni; Jean-Marc Sabatier
              Publication Year: 2025

Plant Metabolomics: The Future of Anticancer Drug Discovery

              Authors: Ranin Dabbousy; Mohamad Rima; Rabih Roufayel; Mohamad Rahal; Christian Legros; Jean-Marc Sabatier;                Ziad Fajloun
              Publication Year: 2024

 From Endogenous Quasi-Pathogens to Endogenous Smart Medicine: Understanding the Cellular Mechanisms and Implications of Benign and Malignant Cell Dynamics

              Authors: Jean-Marc Sabatier; Farzan Amini
              Publication Year: 2024